161 related articles for article (PubMed ID: 9873102)
1. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma.
Fu KK
Semin Radiat Oncol; 1998 Oct; 8(4):247-53. PubMed ID: 9873102
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
[TBL] [Abstract][Full Text] [Related]
3. Controversies in the management of locoregionally advanced nasopharyngeal carcinoma.
Chan AT; Teo PM; Johnson PJ
Curr Opin Oncol; 1998 May; 10(3):219-25. PubMed ID: 9619358
[TBL] [Abstract][Full Text] [Related]
4. Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma.
Chua DT; Sham JS; Wei WI; Ho WK; Au G; Choy D
Head Neck; 2002 Apr; 24(4):350-60. PubMed ID: 11933177
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.
El-Weshi A; Khafaga Y; Allam A; Mosseri V; Ibrahim E; El-Serafi M; El-Badawi S
Acta Oncol; 2001; 40(5):574-81. PubMed ID: 11669328
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
8. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
[TBL] [Abstract][Full Text] [Related]
9. The role of chemotherapy in the management of nasopharyngeal carcinoma.
Chan AT; Teo PM; Leung TW; Johnson PJ
Cancer; 1998 Mar; 82(6):1003-12. PubMed ID: 9506343
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
;
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
[TBL] [Abstract][Full Text] [Related]
13. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
14. Advances in nasopharyngeal carcinoma.
O'Meara WP; Lee N
Curr Opin Oncol; 2005 May; 17(3):225-30. PubMed ID: 15818165
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer.
Lin JC; Jan JS; Hsu CY
Am J Clin Oncol; 1997 Feb; 20(1):6-10. PubMed ID: 9020279
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma: the Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy.
Clark JR; Norris CM; Dreyfuss AI; Fallon BG; Balogh K; Anderson RF; Chaffey JT; Andersen JW; Miller D
Ann Otol Rhinol Laryngol; 1987; 96(5):608-14. PubMed ID: 3674660
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoma of the nasopharynx. Radiotherapy modalities and combined radiotherapy and chemotherapy: state of the art and perspectives].
Daoud J; Frikha M
Cancer Radiother; 2001 Nov; 5 Suppl 1():195s-200s. PubMed ID: 11797282
[TBL] [Abstract][Full Text] [Related]
19. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
Hu QY; Liu P; Wang L; Fu ZF
Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
[TBL] [Abstract][Full Text] [Related]
20. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
